IP Library Granted Patent US 7,537,791
Granted Patent B2
US 7,537,791 · App. 11/677,435 · Granted May 26, 2009

Parthenolide free bioactive ingredients from feverfew (

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,537,791
App. No.
11/677,435
Granted
May 26, 2009
Kind
B2
Abstract

The present invention relates to bioactive ingredients that include isolated bioactive fractions derived from cell juice of fresh biomass of a feverfew ( Tanacetum parthenium ) plant. The bioactive fractions are either free of or substantially free of α-unsaturated γ-lactones (e.g., parthenolide). Further, the bioactive fractions have anti-inflammatory and antioxidant activity. The present invention also relates to a method for isolating a bioactive fraction that is derived from cell juice of fresh biomass of a feverfew ( Tanacetum parthenium ) plant and that is at least substantially free of α-unsaturated γ-lactones (e.g., parthenolide). The present invention also relates to a method for preparing a stabilized cell juice serum fraction and a stabilized concentrated cell juice serum fraction that are free of α-unsaturated γ-lactones (e.g., parthenolide). The present invention also relates to a bioactive composition that includes a mixture of one or more of the isolated bioactive fractions of the present invention.

Claims (18)

1. A method for isolating a bioactive fraction that is derived from cell juice of fresh biomass of a feverfew ( Tanacetum parthenium ) plant and that is substantially free of α-unsaturated γ-lactones, said method comprising:

providing fresh biomass of a feverfew ( Tanacetum parthenium ) plant;

processing the fresh biomass under conditions effective to yield a cell juice supernatant that is at least substantially free of α-unsaturated γ-lactones and a membrane fraction containing α-unsaturated γ-lactones, said processing the fresh biomass comprising:

(i) separating the fresh biomass into a cell juice component and a fiber enriched material; and

(ii) subjecting the cell juice component to a combined pH adjustment and microwave treatment step to yield the cell juice supernatant that is at least substantially free of α-unsaturated γ-lactones, wherein the pH adjustment comprises decreasing the pH to a range of 3 to 4;

treating the cell juice supernatant under conditions effective to yield a first cell juice serum supernatant and a cytoplasm fraction precipitate; and

isolating the cytoplasm fraction precipitate, wherein said cytoplasm fraction precipitate is a bioactive fraction that is substantially free of α-unsaturated γ-lactones, wherein said α-unsaturated γ-lactones comprise parthenolide.

2. The method according to claim 1 , wherein the step of processing the fresh biomass further comprises:

clarifying the cell juice component to yield a clarified cell juice component prior to subjecting the cell juice component to the combined pH adjustment and microwave treatment step.

3. The method according to claim 1 further comprising:

clarifying the first cell juice serum supernatant under conditions effective to yield a second cell juice serum supernatant;

mixing a stabilizing agent with the second cell juice serum supernatant under conditions effective to yield a stabilized cell juice serum fraction,

wherein said stabilized cell juice serum fraction is a bioactive fraction that is substantially free of α-unsaturated γ-lactones, said α-unsaturated γ-lactones comprising parthenolide.

4. The method according to claim 3 further comprising:

concentrating the stabilized cell juice serum fraction under conditions effective to yield a concentrated cell juice serum supernatant.

5. The method according to claim 4 further comprising:

mixing a stabilizing agent with the concentrated cell juice serum supernatant under conditions effective to yield a stabilized concentrated cell juice serum fraction,

wherein said stabilized concentrated cell juice serum fraction is a bioactive fraction that is free of α-unsaturated γ-lactones, said α-unsaturated γ-lactones comprising parthenolide.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2020
From: THE BANK OF NOVA SCOTIA
To: AVOCA LLC; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES LLC
Reel/Frame 051557/0504 →
SECURITY AGREEMENT Recorded Jul 3, 2017
From: AVOCA, INC.; HERCULES LLC; ISP INVESTMENTS LLC; PHARMACHEM LABORATORIES, INC.
To: THE BANK OF NOVA SCOTIA, AS ADMINISTRATIVE AGENT
Reel/Frame 043084/0753 →
CHANGE OF NAME Recorded May 22, 2017
From: ISP INVESTMENTS INC.
To: ISP INVESTMENTS LLC
Reel/Frame 042521/0083 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 16, 2015
From: AKZO NOBEL SURFACE CHEMISTRY LLC; AKZO NOBEL CHEMICALS INTERNATIONA B.V.
To: ISP INVESTMENTS INC.
Reel/Frame 036583/0320 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2011
From: INTEGRATED BOTANICAL TECHNOLOGIES, LLC
To: AKZO NOBEL SURFACE CHEMISTRY LLC
Reel/Frame 027406/0905 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2007
From: KOGANOV, MICHAEL
To: INTEGRATED BOTANICAL TECHNOLOGIES, LLC
Reel/Frame 019062/0771 →